Summary of STERIS plc (NYSE:STE) Ratings as of Jun 27, 2018

June 27, 2018 - By Marcos Kline

STERIS plc (NYSE:STE) Corporate Logo
During 2018 Q1 the big money sentiment increased to 0.33. That’s change of 0.16, from 2017Q4’s 0.17. 2 investors sold all, 1 reduced holdings as STERIS plc ratio is positive. 0 rose positions while 1 funds took positions. Funds hold 21,503 shares thus 9.44% more from 2017Q4’s 19,649 shares.
Prudential Public Ltd Co holds 0% or 3,800 shs. Fruth Invest accumulated 0.55% or 13,276 shs. Alphamark Ltd Liability Corporation holds 150 shs or 0.01% of its capital. Eqis Capital Management stated it has 4,277 shs or 0.02% of all its holdings.

STERIS plc (NYSE:STE) Ratings Coverage

In total 3 analysts cover STERIS (NYSE:STE). “Buy” rating has 2, “Sell” are 0, while 1 are “Hold”. (NYSE:STE) has 67% bullish analysts. 3 are the (NYSE:STE)’s ratings reports on Jun 27, 2018 according to StockzIntelligence Inc. On Thursday, February 8 the stock of STERIS plc (NYSE:STE) earned “Buy” rating by KeyBanc Capital Markets. On Thursday, February 8 the rating was maintained by Northcoast with “Buy”. On Wednesday, January 3 the rating was downgraded by Raymond James to “Market Perform”. Listed here are STERIS plc (NYSE:STE) PTs and latest ratings.

08/02/2018 Broker: KeyBanc Capital Markets Rating: Buy New Target: $103.0 Maintain
08/02/2018 Broker: Northcoast Rating: Buy New Target: $102.0 Maintain
03/01/2018 Broker: Raymond James Old Rating: Outperform New Rating: Market Perform Old Target: $100 Downgrade

The stock increased 0.32% or $0.34 during the last trading session, hitting $105.09.Currently STERIS plc is uptrending after 34.02% change in last June 27, 2017. STE has 316,343 shares volume. STE outperformed the S&P500 by 21.45%.

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support services and products for healthcare, pharmaceutical, scientific, research, industrial, and governmental clients worldwide.The firm is valued at $8.89 billion. The companyÂ’s Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories.The P/E ratio is 37.02. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products.

There’s an important STERIS plc (NYSE:STE) news published by It’s an item titled: “Research Report Identifies STERIS plc, Parker-Hannifin, Sturm, Ruger, CoBiz Financial, Black Hills, and Glacier with …” on June 22, 2018.

STERIS plc (NYSE:STE) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: